CD274 and osteosarcoma: Studies using preclinical osteosarcoma mouse models showed reduced metastasis and prolonged survival when mice were treated with anti-PD-1 antibody or a combination containing anti-PD-1 and anti-PD-L1 antibodies [42], [43].